Civic Intelligence

Newman-Lakka Cancer Foundation C/O Charles Newman

990 • Fiscal year 2013 • EIN 45-3956797

Nov 01, 2012 to Oct 31, 2013

Scottsdale, AZ
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

74th percentile

0.07x

Higher debt load relative to assets than 74% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Liabilities / Revenue

63rd percentile

0.01x

Higher debt load relative to revenue than 63% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Net Margin

84th percentile

29%

Higher net margin than 84% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

78th percentile

29%

Faster asset growth than 78% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Annualized from 2012 to 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

Up

$59,659

Up $13,282 (+29%) from 2012

Net Assets

Up

$55,417

Up $135,781 (+169%) from 2012

Liabilities

Down

$4,242

Down $122,499 (-97%) from 2012

Revenue

$469,112

No earlier filing loaded for comparison.

Expenses

Down

$333,331

Down $72,136 (-18%) from 2012

Net Income

$135,781

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0-$100KAssets 2012: $46,377Liabilities 2012: $126,741Net Assets 2012: -$80,3642012Assets 2013: $59,659Liabilities 2013: $4,242Net Assets 2013: $55,4172013Assets 2014: $199,559Liabilities 2014: $89,976Net Assets 2014: $109,5832014Assets 2015: $125,978Liabilities 2015: $148,388Net Assets 2015: -$22,4102015Assets 2016: $89,131Liabilities 2016: $0Net Assets 2016: $89,1312016Assets 2017: $62,417Liabilities 2017: $8,190Net Assets 2017: $54,2272017Assets 2018: $29,415Liabilities 2018: $32,465Net Assets 2018: -$3,0502018Assets 2019: $37,792Liabilities 2019: $32,465Net Assets 2019: $5,3272019Assets 2020: $22,596Net Assets 2020: $22,5962020Assets 2022: $33,098Liabilities 2022: $0Net Assets 2022: $33,0982022Assets 2023: $211,703Liabilities 2023: $0Net Assets 2023: $211,7032023Assets 2024: $277,285Liabilities 2024: $0Net Assets 2024: $277,2852024Assets 2025: $301,748Net Assets 2025: $301,7482025

Highlighted filing

2013

Assets$59,659
Liabilities$4,242
Net Assets$55,417

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KExpenses 2012: $405,4672012Revenue 2013: $469,112Expenses 2013: $333,331Net Income 2013: $135,7812013Revenue 2014: $872,310Expenses 2014: $825,116Net Income 2014: $47,1942014Revenue 2015: $197,001Expenses 2015: $326,662Net Income 2015: -$129,6612015Revenue 2016: $194,370Expenses 2016: $87,462Net Income 2016: $106,9082016Revenue 2017: $85,732Expenses 2017: $115,586Net Income 2017: -$29,8542017Revenue 2018: $21,325Expenses 2018: $78,601Net Income 2018: -$57,2762018Revenue 2019: $20,942Expenses 2019: $12,446Net Income 2019: $8,4962019Revenue 2020: $10,880Expenses 2020: $26,076Net Income 2020: -$15,1962020Revenue 2022: $145,277Expenses 2022: $26,638Net Income 2022: $118,6392022Revenue 2023: $29,827Expenses 2023: $6,072Net Income 2023: $23,7552023Revenue 2024: $10,095Expenses 2024: $33,306Net Income 2024: -$23,2112024Revenue 2025: $66,846Expenses 2025: $56,118Net Income 2025: $10,7282025

Highlighted filing

2013

Revenue$469,112
Expenses$333,331
Net Income$135,781
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Nov 1, 2012 to Oct 31, 2013
Mission and Program Overview

Mission

Form 990 - organization's mission to improve the standard of care and treatment outcomes for all cancer patients by supporting and establishing innovative care, that will accelerate the transformation of cancer into a manageable disease and improve survival and quality of life. Form 990, part iii, line 4d - all other accomplishment to improve the standard of care and treatment outcomes for all cancer patients by supporting and establishing innovative care, that will accelerate the transformation of cancer into a manageable disease and improve survival and quality of life. Form 990, part vi, line 11b - organization's process to review from 990 no review was or will be conducted form 990, part vi, line 19 - governing documents disclosure explanation no documents available to the public

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings